Galectin-3: A Novel Marker for the Prediction of Stroke Incidence and Clinical Prognosis
Stroke, whether ischemic or haemorrhagic, is one of the main causes of mortality and disability all over the world, which entails huge burdens in both healthcare environments as well as social and economic aspects of life. Therefore, there is a continuous search for novel reliable biomarkers that ca...
Saved in:
Main Authors: | Ahmed Sayed, Malak Munir, Mohamed S. Attia, Badrah S. Alghamdi, Ghulam Md Ashraf, Eshak I. Bahbah, Mohamed Elfil |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2022/2924773 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plasma galectin-3 can be considered as a non-invasive marker to predict the prognosis of ACLF patients with new typing
by: Li Bai, et al.
Published: (2025-01-01) -
Galectins as New Prognostic Markers and Potential Therapeutic Targets for Advanced Prostate Cancers
by: Diego J. Laderach, et al.
Published: (2013-01-01) -
Comparative analysis of galectin-1, galectin-3, and galectin-8 signatures in normal and choriocarcinoma trophoblast cell lines
by: Jovanović Krivokuća Milica, et al.
Published: (2024-01-01) -
Editorial: Galectins and hormones in health and disease
by: María F. Troncoso, et al.
Published: (2025-02-01) -
The Role of Galectins as Modulators of Metabolism and Inflammation
by: Monica Fengsrud Brinchmann, et al.
Published: (2018-01-01)